Form 8-K - Current report:
SEC Accession No. 0001213900-25-025779
Filing Date
2025-03-31
Accepted
2025-03-31 08:26:06
Documents
15
Period of Report
2025-03-27
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0236226-8k_synergy.htm   iXBRL 8-K 27929
2 PRESS RELEASE, DATED MARCH 31, 2025 ea023622601ex99-1_synergy.htm EX-99.1 110972
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2927
  Complete submission text file 0001213900-25-025779.txt   328717

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE snyr-20250327.xsd EX-101.SCH 3020
5 XBRL LABEL FILE snyr-20250327_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE snyr-20250327_pre.xml EX-101.PRE 22362
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0236226-8k_synergy_htm.xml XML 3528
Mailing Address 865 SPRING STREET WESTBROOK ME 04092
Business Address 865 SPRING STREET WESTBROOK ME 04092 615-939-9004
Synergy CHC Corp. (Filer) CIK: 0001562733 (see all company filings)

EIN.: 990379440 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42374 | Film No.: 25789052
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)